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1. Introduction
  Annona senegalensis (A. senegalensis) Pers. (Annonaceae) 
is a shrub or small tree of about 2-6 m tall mostly found 
in the savanna and parts of tropical rain forest regions. It 
is found in Senegal, Nigeria, Cape Verde Island, Sudan 
and South Africa. A. segalensis is commonly known as 
African custard-apple, wild custard apple and wild sour 
sop[1,2]. It has aromatic flowers which are used to flavour 
food. The ripe fruit is yellow in colour and has a sweet 
edible jelly with pleasant odour. Common vernacular 
names are "Uburu ocha" (Igbo), "gwandar daajii" (Hausa), 
"arere" or "abo" (Yoruba), "Ukpokpo" (Igala), "ngonowu" 
(Kanuri), "uwu" (Idoma), "mkonokono" (Swahili)[3]. A. 
senegalensis is variously used in ethnomedicine for the 
treatment of different kinds of ailments and as such enjoys 
great reputation for its immense ethnomedicinal value. 
A. senegalensis has been reported to have antibacterial 
activity[4], antidiarrhoeal activity[5]. The anticonvulsant 
effects of the whole root extract has been reported[6]. The 
analgesic, anti-inflammatory activity[7,8], trypanocidal 
activity[9,10] and anti-snake venom activity[3], have been 
investigated. Also essential oils from the leaves of A. 
senegalensis exhibited antibacterial activity[11]. The plant 
decoction is used in the treatment of sleeping sickness in 
Northern Nigeria[12] as well as for the folkloric treatment 
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of cancer[13,14] and malarial infection[15]. Recently, there 
are reports of the anticonvulsant, muscle relaxant and 
sedative effects of the root bark of A. senegalensis[16] and 
the neuro pharmacological activities of the leaf extracts[17]. 
In consideration of the diverse use of various parts of 
A. senegalensis for the management of many ailments in 
the Nigerian traditional medicine practice and the high 
edible application of the fruits, we set to evaluate the 
acute and sub-acute toxicity of its root bark extracts using 
experimental animals.
2. Materials and methods
2.1. Animals
  Adult albino rats (100-200 g) of either sex bred in the 
laboratory animal facility of the Department of Pharmacology 
and Toxicology, University of Nigeria, Nsukka, were used 
for the study. The animals were maintained at the normal 
room temperature (25±1)℃ with a 12 h light : 12 h dark 
cycle and allowed free access to standard pellets and water. 
All animal experiments were conducted in compliance with 
the National Institute of Health Guidelines for Care and Use 
of Laboratory Animals (Pub No. 85-23, revised 1985) and 
under approval of the University Ethical Committee on the 
use of laboratory animals. 
2.2. Preparation of extracts
  The fresh root barks of A. senegalensis were collected 
in June from Enugu Ezike, in Enugu State, Nigeria. 
The plant material was identified and authenticated at 
the International Centre for Ethnomedicine and Drug 
Development (InterCEDD), Nsukka, Enugu State, where a 
voucher specimen was deposited (specimen number: BDCP/
INTERCEDD 64). The plant material was air dried under 
shade to a constant weight and later pulverized into coarse 
powder. About 2.95 kg of the pulverized plant material was 
extracted using soxhlet apparatus at reduced pressure with 
methanol-methylene chloride (1:1). The extract (MME) 
obtained was concentrated using a rotary evaporator to 
obtain a chocolate colored gummy residue 375 g (12.71% 
w/w). Subsequently 200 mg of MME was fractionated 
chromatographically with n-hexane, ethyl acetate and 
methanol to obtain hexane fraction (HF), Ethyl acetate 
fraction (EF) and methanol fraction (MF) respectively.  
2.3. Phytochemical analysis
  The extracts and fractions were subjected to phytochemical 
analysis using standard procedures[18,19]. 
2.4. Acute toxicity tests
  The acute toxicity and lethality of the MME and fractions 
were determined using the method described by Lorke[20]. 
Briefly, 9 rats were randomly divided into three groups (n=3), 
and were orally administered with 10, 100, and 1 000 mg/kg of 
the MME, respectively. They were observed for 24 h for death. 
Since no death was recorded, 1 600 mg/kg, 2 900 mg/kg and 
5 000 mg/kg of the extracts were administered to a fresh 
batch of animals at one animal per dose and the number of 
deaths in 24 h was recorded. This procedure was repeated 
for each of the various fractions HF, EF and ME.
2.5. Sub-acute toxicity tests
  Rats were randomly placed in groups (n=5). While group 
1 received daily oral administrations of the vehicle (1:1, 
20% Tween 80 and propylene glycol, 10 mL/kg) groups 
2-4 received 50, 100 or 400 mg/kg of the MME for 14 days, 
respectively. Body weights of the animals were recorded 
on day 0, 7, and 14. At the end of the experiment, blood 
was collected from the orbital sinus for biochemical 
and hematological analysis. Subsequently the animals 
were sacrificed and selected organs (liver, heart, spleen, 
kidney and lung) were removed for macroscopic analysis. 
The biochemical enzymes evaluated include alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST) 
which were assessed using the commercial kits[21]. The 
hematological parameters determined included the packed 
cell volume (PCV), total white blood cell (WBC) count and 
differential WBC count. The liver tissue specimens were 
sectioned for histopathological studies[22]. 
2.5.1. Hematological analysis 
  The blood samples were placed in a well labeled sample 
bottles containing ethylene diamine tetraacetic acid (EDTA). 
The sample bottle was shaken gently to mix the blood with 
EDTA to prevent clotting.
  The PCV was determined using microhematocrit centrifuge 
(Hawksley, England). A micro capillary tube sealed with 
plastacine at one end was nearly filled with blood sample 
and centrifuged in the equipment at 10 000 r/min for 5 
minutes. After centrifugation, the PCV was read using a 
Hawksley microhematocrit reader.
  The blood, 0.02 mL, was diluted in 0.38 mL of WBC diluting 
fluid (Turk's solution) to make a 1:20 dilution of the blood. 
The diluted sample was loaded in a Neubauer Counting 
Chamber and all the cells on the 4 corner square (1 mm2) 
areas were counted using a light microscope of 暳10 objective. 
The number of cells counted for each blood sample was 
multiplied by 50 to obtain the total WBC count per micro 
liter of blood[22]. 
  The blood sample was shaken gently and a drop of blood 
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was placed on a clean grease-free slide. A thin smear of 
blood was made on the slide using a cover slip. The smear 
was allowed to air-dry and was stained using Leishman 
stain. The stained slides were later examined under oil 
immersion 暳100 objective, using a light microscope. 
Result for each type of white blood cell was expressed as a 
percentage of the total count converted to the absolute value 
per micro liter of blood.
2.5.2. Liver function analysis
  The effect of the extract on the ALT (SGPT) and AST (SGOT) 
was determined using Randox Assay kit. The GPT and GOT 
substrate solution (reagent A), 0.5 mL each, for ALT and 
AST respectively, was placed into the labeled test tubes 
and incubated for 5 min at 37 ℃. After the incubation, 
0.1 mL of the serum sample was added in the test tubes 
and incubated for 30 min at 37 ℃. Then 0.5 mL of color 
developer (reagent B) was added and then allowed to stand 
for 20 min at room temperature (25-26 ℃). 5 mL of dilute 
NaOH solution (reagent C) was added and allowed to stand 
for 15 min at room temperature. The transmittance was read 
at 505 nm against water blank. The mixture was stable for up 
to 1 h. The ALT and AST activities (毺/L) were obtained by 
interpolating the transmittance into the calibration curve[21].
2.5.3. Histopathological examination of the liver
  The rats were sacrificed, dissected and their livers carefully 
collected and fixed in 10% buffered formalin solution. 
Histologic sections were prepared from the livers and were 
fixed in bouin's solution (mixture of 75 mL of saturated 
picric acid, 25 mL of 40% formaldehyde and 5 mL of glacial 
acetic acid) for 12 h. This was embedded in paraffin using 
conventional method and cut into 5 毺m thick sections and 
stained using hematoxylin-eosin dye and finally mounted 
in diphenyl xylene[23]. The sections were then observed 
under the microscope for histopathological changes in liver 
architecture and their photomicrographs were taken.
2.5.4. Organ toxicity
  The gross examination (macroscopic analysis) of the target 
organs of the control and treated animals were done to check 
any significant change in weight, texture and shape. The 




  The statistical analysis of data obtained were done by 
One Way ANOVA and subjected to Dunnett's post hoc Test, 
where the data were compared with the control. The mean 
difference is significant at P<0.05 level and values were 
stated as Mean暲SEM.
3. Results
3.1. Phytochemical tests 
  
  Phytochemical tests of the extracts and fractions 
revealed the moderate presence of alkaloids, glycosides, 
carbohydrates and steroids, while flavonoids, terpenoids and 
resins were quite in abundance in the extracts and fractions 
(Table 1). 
 
3.2. Acute toxicity tests 
  The acute lethality and toxicity (LD50) tests of the extract 
and fractions showed an estimated LD50 values of 1 296, 
3 808, 1 265 and 2 154 mg/kg for the MME, MF, HF and EF, 
respectively.
3.3. Effect of extract on body weight
 
  The body weight of all the rats increased considerably with 
respect to their initial weight. At 400 mg/kg dose the extract 
exhibited significant (P<0.05) increase in body weight. The 
 Table 1
 Phytochemical constituents of extract and fractions.
Constituent MME EF HF MF
Carbohydrate ++ - - ++
Alkaloid +++ ++ ++ ++
Reducing sugar ++ - - ++
Glycoside +++ - - +++
Saponins + - - +
Tannins - - - -
Flavonoids ++++ ++++ - -
Resin ++++ ++ ++++ ++
Fats and oils + + + -
Steroids +++ - ++ +
Terpenoids ++++ ++ +++ ++
Acidic compounds - - - -
 - = absent; + = present; ++ = moderately present; +++ = conspicuously present; ++++ = abundantly present.
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weight gain in the extract treated groups was lower than 
in control group. The results show that the extract elicited 
a dose-dependent significant increase in body weight 
compared to the control (Table 2).
3.4. Effect of extract on organ weight
  There was no significant (P>0.05) differences in the weight 
of heart, lung, spleen and kidney of treated and control rats, 
although, the liver weight of the extract treated rats was 
higher than the control (Table 3).
3.5. Effect of extract on hematological parameter
  There was no significant (P>0.05) change in the neutrophil 
and lymphocyte counts, of the extracts treated rats when 
compared with the control. The extract exhibited a dose 
dependent increase in the PCV and WBC at same time 
showed a significant increase in WBC count at 100 mg/kg 
dose (Table 4).  
3.6. Effect of extract on serum biochemical parameters
  There was no significant (P>0.05) difference in the levels of 
ALT and AST between the treated and control groups (Table 
5). This is an indication of no biochemical related changes 
in the hepatic cells.
3.7. Effect of extract on liver architecture
  Histopathological examination of liver section of the control 
group and extract treated groups (50 mg/kg and 100 mg/kg
dose levels), showed normal cellular architecture with 
distinct hepatic cells that are still intact, clear sinusoidal 
spaces and central vein (Figure 1 A-C). While the 400 mg/kg 
treated group showed a clear sinusoidal spaces and central 
vein, with mild sign of inflamed portal tracts between 
different lobules and showed degeneration and necrosis of the 
hepatocytes (Figure D). Gross anatomical observation of the 
Table 2
Effect of extract on body weight (Mean依SEM).
Treatment Dose (mg/kg)
Body weight (g)
Day 0 Day 7 Day 14
Control 102.00 依 3.39 120.60 依 3.22 131.00 依 3.85 
MME   50 100.00 依 3.52 116.25 依 3.15 126.00 依 2.16     
100   109.00 依 4.56* 120.80 依 6.41 129.60 依 7.91 
400     117.20 依 2.33**     133.00 依 3.86** 137.00 依 4.12 
Significance at *P<0.05; **P<0.001, vs. control group. 
Table 3
Effect of extract on organ weight(Mean依SEM, n=5).
Treatment Dose (mg/kg)
Weight (g)
Heart Lung Spleen Liver Kidney
Control 0.43依0.48 1.08依0.13 0.98依0.11 5.95依0.18 0.45依0.03
MME 50 0.40依0.00 0.93依0.08 1.08依0.13 6.75依0.10 0.38依0.03
100 0.53依0.25 0.93依0.09 1.13依0.16 7.43依0.71 0.48依0.03
400 0.48依0.03 0.98依0.08 0.80依0.11 6.33依0.43 0.43依0.03
Table 4
Effect of extract on haematological parameters(Mean依SEM, n=5).
Treatment Dose (mg/kg) PCV WBC
Differential
Neutrophil Lymphocyte
Control 37.50 依 1.71 10.90 依 1.58 28.50 依 8.02 70.75 依 8.01
MME   50 29.25 依 4.15   9.08 依 1.27 27.75 依 6.36 72.00 依 6.38
100 37.25 依 1.38   17.35 依 2.08* 16.50 依 1.94 83.25 依 2.14
400 38.00 依 1.87 14.98 依 0.98 17.25 依 1.70 82.25 依 2.17
*P<0.05; vs. control group. 
Table 5
Effect of extract on liver enzymes(Mean依SEM, n=5) (IU/L).
Treatment Dose (mg/kg) ALT AST
Control 33.00 依 2.68 70.50 依 6.45
MME   50 31.00 依 7.80   56.75 依 20.70
100 33.25 依 2.69 74.75 依 5.20
400 27.00 依 2.74 72.75 依 6.43
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liver showed a distinct inflammed liver organ with 400 mg/kg 
treated group compared with the control group.
A                                                                       B
C                                                                       D
Figure 1. Photomicrographs of the Liver(伊400, H & E).
A: Control; B: MME 50 mg/kg; C: MME 100 mg/kg; D: MME 400 mg/
kg.
4. Discussions
  The use of medicinal plants to manage ailments is very 
common especially in rural areas of Nigeria, where about 
70% of the populace reside. Preparations of A. senegalensis 
are used in the management of a wide range of ailments 
ranging from gastrointestinal disturbances, central nervous 
system disorders to cancer. In addition the fruit offers an 
edible source to the people. The importance of the plant 
in folk medicine, its popularity and high demand, as well 
as its promising pharmacological potentials make this 
toxicological studies on it imperative. The acute lethality, 
LD50, of the extracts and fractions indicated a relatively 
high safety profile[20]. The increase in body weight after 
drug administration usually indicate absence of toxicity 
as decrease in body weight is an index of toxic effect of a 
compound[24-29]. In this study, the weight of the vital organs 
(the heart, lung, spleen and kidney) after the treatment 
period indicated no significant obvious change. However, 
the liver showed slight non dose dependent increase in 
weight. The macroscopic examination of these target 
organs showed no significant changes in colour, shape and 
texture when compared with the control. This probably may 
have ruled out any organ toxicity at the doses tested. The 
extract showed no obvious alterations in the haematological 
parameters at the doses tested. The results indicated no 
significant (P>0.05) increase in the PCV values but exhibited 
dose dependent increase in the total WBC count which 
was significant (P<0.05) at 100 mg/kg dose. This increase 
might probably be as a result of increase in the lymphocyte 
level which was evident in the differential WBC count. 
The degree of immunological stimulation is one of the 
important factors responsible for the increased circulating 
lymphocytes in the body[30] and this might suggests possible 
immune modulatory effects of the extract, which is a point 
for further research. Moreover, the differential test showed 
no increase in the number of circulating neutrophils. On 
the other hand the serum biochemical parameters did not 
show any significant increase. The activities of the liver 
marker enzymes ALT and AST remain insignificant variations 
compared with the control animals. Although there was 
insignificant increase in AST values as observed in 100 and 
400 mg/kg treated groups, this could not amount to any 
noticeable alterations in the activity and morphology of the 
liver cells in the treated animals. High values of serum ALT 
and AST have been implicated in liver necrosis, hepatitis, 
toxic liver diseases and acute myocardial infarction and 
ALT is one of the plasma cardiac markers that increase 
sequentially after acute myocardial infarction[31,32]. A rise 
in the activities of ALT and AST is a sensitive indicator of 
damage to cytoplasmic and mitochondrial membranes and 
their relative plasma activities may help to indicate the 
type of hepatic damage whenever it manifested[33]. The 
histopathological studies showed no prominent hepatic 
damages/injuries in the control and treated animal groups
(50 mg/kg and 100 mg/kg) while disclosing some degree of 
degeneration and necrosis of the hepatocytes. Therefore, the 
histopathological findings of the liver in this study, calls for 
caution when using the extract at higher doses as this may 
lead to damage of the liver cells as found in the animals that 
received 400 mg/kg dose. Meanwhile the phytochemical tests 
revealed the abundant presence of flavonoids, terpenoids, 
resins, alkaloids and moderate presence of glycosides, 
steroids in the extracts and fractions. The presence of these 
phyto-constituents is correlated with those present in the 
methanol root bark extract of A. senegalensis. The observed 
toxicity with the 400 mg/kg dose could not be ascribed to 
a particular constituent(s) at this stage of the work. The 
variations in the degree of presence of these phytochemicals 
in the fractions may have been responsible for the different 
lethality values exhibited by the fractions, though they all 
manifested high level of safety.   
  In conclusion, the root bark extract of A. senegalensis 
possesses no obvious significant toxic effects and the doses 
treated excerpt at 400 mg/kg dose exhibit no significant 
acute lethality on the treated animals. This overall findings 
buttress the fact that local dwellers in different parts of the 
savanna and rainforest zones have been using parts of A. 
senegalensis for medicinal purposes and the juicy fruits as 
edible for many years without obvious complaints or toxicity.
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